#BioFront - Twitter Hashtag

3 months ago

So many highlights for this year’s #SWOGSpring26 but this takes the cake…#BIOFRONT is activated!! Incredibly excited for this #clinicaltrial for #metastatic #kidneycancer patients. @PBarataMD & team have worked so hard on this, and it shows. @SWOG @SupportingSWOG #GUonc

Pedro C Barata, MD MSc FACP

@PBarataMD

3 months ago

Excited to see this highlighted 👇 The gut microbiome may play a meaningful role in kidney cancer outcomes—and we’re now testing this prospectively in the BIOFRONT (S2419) trial. A simple oral intervention (CBM588) + immunotherapy → could reshape how we think about treatment. @UHhospitals @SWOG @montypal @DrVaishampayan @caseccc #KidneyCancer #Oncology #Immunotherapy #Microbiome https://t.co/wf7avo4eDM

1

26

4

3

4K

2

11

6

0

2K

Pedro C Barata, MD MSc FACP

@PBarataMD

3 months ago

@neerajaiims @SWOG @montypal @DrVaishampayan @slernerbcmedu1 @kidneycan @DrChoueiri @BraunMDPhD @PGrivasMDPhD @TiansterZhang @shilpaonc @apolo_andrea @brian_rini @umangtalking @maughanonc @ggebraelmd @BradMcG04 Thank you @neerajaiims for highlight! We have an amazing team @swog w hands on this trial👇Excited to see #BioFront and gaining momentum!!

PBarataMD's tweet photo. @neerajaiims @SWOG @montypal @DrVaishampayan @slernerbcmedu1 @kidneycan @DrChoueiri @BraunMDPhD @PGrivasMDPhD @TiansterZhang @shilpaonc @apolo_andrea @brian_rini @umangtalking @maughanonc @ggebraelmd @BradMcG04 Thank you @neerajaiims for highlight! We have an amazing team @swog w hands on this trial👇Excited to see #BioFront and gaining momentum!! https://t.co/oh5z006hyb

1

13

0

2K

Miguel Zugman, MD @mzugman

3 months ago

Grateful to @TiansterZhang for this conversation on @cityofhope Phase I study of #CBM588 + nivo/ipi in mccRCC led by @arafflemd. Early work helping pave the way for the @SWOG #BioFront study. Also had the chance to discuss other COH trials and my transition back to Brazil!

UroToday.com

@urotoday

3 months ago

Phase I trial explores formulation of CBM588 probiotic in advanced #RCC. @mzugman @cityofhope joins @TiansterZhang @UTSWMedCenter presenting phase I dose escalation results testing refrigerated capsule formulation of CBM588 probiotic with nivolumab/ipilimumab in 12 first-line metastatic clear cell renal cell carcinoma patients. #WatchNow > https://t.co/ScR850NIMU

urotoday's tweet photo. Phase I trial explores formulation of CBM588 probiotic in advanced #RCC. @mzugman @cityofhope joins @TiansterZhang @UTSWMedCenter presenting phase I dose escalation results testing refrigerated capsule formulation of CBM588 probiotic with nivolumab/ipilimumab in 12 first-line metastatic clear cell renal cell carcinoma patients. #WatchNow > https://t.co/ScR850NIMU

0

14

2

0

2K

1

25

3

0

901

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang

3 months ago

#RuchiAgarwal steals the show at posters #IKCSEU26, presenting data from @montypal CBM588 trials, supporting future microbiome modulating trials like @SWOG #BIOFRONT. Congrats!! @OncoAlert @KidneyCancer